Table 1c.
Probability estimates of side effects for contraceptive methods
Method | Amenorrhea | Venous thromboembolism | Urinary tract infections | Postoperative complications |
---|---|---|---|---|
LNG-20 IUS | 0.2a [13] | |||
Copper-T IUD | ||||
Implant | 0.222 a | |||
Injectable contraceptive | 0.4 b[7] | |||
Tubal ligation | 0.012c[14] | |||
Vasectomy | 0.00043c[14] | |||
Oral contraceptive | 0.03[15] | 0.00005[16] | 0.15[17] | |
Transdermal patch | 0.001[18] | 0.00005 a[16] | ||
Vaginal ring | 0.03[19] | 0.00005 a | ||
Male condom | ||||
Female condom | ||||
Diaphragm | 0.31[17,20] | |||
Spermicides | 0.31d[20,21] | |||
Sponge | ||||
Fertility-awareness-based methods | ||||
Withdrawal | ||||
No method |
IUD, intrauterine device; IUS, intrauterine system.
Source: Package Insert.
Probability of amenorrhea for 3-month injectable contraceptive increases each year to 0.7, 0.75, 0.78, and 0.8, respectively.
First year only.
Assumed to be the same as with the diaphragm.